No Data
Progress Software Posts Upbeat Results, Joins Microvast, PVH And Other Big Stocks Moving Higher On Tuesday
The entire pharmaceutical sector has surged sharply; what happened?
On Monday, all AH Stocks in the pharmaceutical Sector surged, with innovative drugs performing the strongest. The Yinhua CSI Innovative Drugs Industry ETF collectively rose sharply, driven by three main factors: the relaxation of collective procurement, overseas license authorizations, and improvement in Earnings Reports that will reshape the Industry landscape.
Hong Kong stocks movement | Hutchmed (China) (00013) rose over 11% as the overseas sales growth of furmonertinib exceeded guidance, driving the overall performance growth of the company.
Hutchmed (China) (00013) rose over 11%, as of the time of writing, it increased by 10.27, trading at 26.3 Hong Kong dollars, with a transaction volume of 0.241 billion Hong Kong dollars.
Hong Kong stocks movement | Hutchmed (China) (00013) is currently down over 4%, with revenue for 2024 slightly below expectations. Institutions state that the revenue target for the fiscal year 2025 is conservative.
Hutchmed (China) (00013) is currently down over 4%, as of the time of writing, down 4.59%, at HKD 22.85, with a trading volume of 57.2795 million HKD.
HAITONG INT'L: Assigning Hutchmed (China) (00013) an "Outperform" rating with a Target Price of 46.66 HKD.
Management expects that 1-2 ATTC pipelines will enter the clinical stage in the second half of 2025.
Workday's Education Platform Becomes More Competitive Due to Recent Improvements: Needham
